Abstract

Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets

Author(s): Alexander Kenneth S, Kothapalli Madhu R, Dollimor David

Issue: Jan/Feb 1997 - Hospice Care

Page(s): 60-63

Download in electronic PDF format for $75
  • Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets Page 1
  • Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets Page 2
  • Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets Page 3
  • Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets Page 4

Note: Electronic version includes errata or revisions.

Abstract

The stability of a 40-µg/mL extemporaneously formulated syrup from commercially available levothyroxine sodium tablets, using sorbitol 70% as the diluting vehicle, was studied. The concentration of levothyroxine sodium in the formulation was 40 µg/mL. The protocol included accelerated stability testing at temperatures of 40°, 50°, 60° and 70°C and a high-performance liquid chromatography assay procedure using testosterone propionate as the internal standard. The data were analyzed using an Arrhenius plot to determine the shelf-life of the formulation. The shelf-life was found to be approximately 15 days at 25°C and 47 days at 5°C.

Related Keywords

  • Synthroid

Related Categories

  • GERIATRICS
  • PEDIATRICS
  • PEER-REVIEWED
  • STABILITIES, COMPATIBILITIES

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 1997
Pg. 60-63
Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets
Author(s): Alexander Kenneth S, Kothapalli Madhu R, Dollimor David
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Sep/Oct 2000
Pg. 398-399
Stability of Lisinopril Syrup (2 mg/mL) Extemporaneously Compounded from Tablets
Author(s): Rose Deidra J, Webster Andrew A, English Brett A, McGuire J Michael
Sep/Oct 2015
Pg. 414-419
Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules
Author(s): Fortner Jeff, Salton Jason, Carlson Christie, Wheeler Rich, Cote Brianna, Rao Deepa
Mar/Apr 2018
Pg. 164-171
The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions
Author(s): Svirskis Darren, Lin Shao-Wei, Brown Helen, Sangaroomthong Annie, Shin Daniel, Wang Ziqi, Xu Hongtao, Dean Rebecca, Vareed Preetika, Jensen Maree, Wu Zimei
Nov/Dec 2000
Pg. 482-483
Stability of Levothyroxine Sodium Injection in Polypropylene Syringes
Author(s): Gupta Vishnu D
May/Jun 2004
Pg. 206-209
Basics of Compounding for Cold Sores or Fever Blisters
Author(s): Allen Loyd V Jr
Jan/Feb 2020
Pg. 77-82
Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets
Author(s): Jarouche Marian, Ibrahim Martha, Pearson Jarryd, Low Mitchell, Rowe James
Jul/Aug 2012
Pg. 342-346
Formulation and Stability Evaluation of Extemporaneously Prepared Atenolol Capsules from Crushed Atenolol Tablets
Author(s): Zaid Abdel Naser, Malkieh Numan, Kharoaf Maher, Ghoush Abeer Abu, Al-Ramahi Rowa'
Jul/Aug 2018
Pg. 326-328
Stability of Extemporaneously Prepared Sodium Benzoate Oral Suspension
Author(s): Atkins Julia R, Lull Melinda E, Decker Andrew S, Hutchinson David J
Nov/Dec 2013
Pg. 505
Levothyroxine Sodium 100-mcg Capsules
Author(s): Allen Loyd V Jr
May/Jun 2007
Pg. 247
Levothyroxine Sodium 40-micro-g/mL Oral Liquid
Author(s): Allen Loyd V Jr
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
Sep/Oct 2015
Pg. 428-431
Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures
Author(s): Nahata Milap C
Jan/Feb 2021
Pg. 82-87
Physical-chemical Stability of Compounded Sildenafil 100-mg Rapid-dissolving Tablets
Author(s): Cheung Matthew, Zhao Fang, Dave Vivek S
Sep/Oct 2021
Pg. 431-439
Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt
Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
May/Jun 2022
Pg. 255-263
Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets
Author(s): Liew Kai Bin, Hii Shou Hui, Chew Yik Ling, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam
May/Jun 2002
Pg. 226-229
Stability of Ampicillin Sodium, Nafcillin Sodium, and Oxacillin Sodium in AutoDose Infusion System Bags
Author(s): Zhang Yanping, Trissel Lawrence A
Mar/Apr 2020
Pg. 148-155
Comparison of Disintegrant-addition Methods on the Compounding of Orodispersible Tablets
Author(s): Mahesparan Vishnu A/L, Bin Abd Razak Fashli Syafiq, Ming Long Chiau, Uddin ABM Helal, Sarker Md Zaidul Islam, Bin Liew Kai
May/Jun 2003
Pg. 233-239
Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets
Author(s): Kaila Nitin, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D